MYLAN SM 25 MYLAN SM 25 Pill - brown & yellow capsule-shape, 18mm
Pill with imprint MYLAN SM 25 MYLAN SM 25 is Brown & Yellow, Capsule-shape and has been identified as Sunitinib Malate 25 mg. It is supplied by Mylan Pharmaceuticals Inc.
Sunitinib is used in the treatment of Gastrointestinal Stromal Tumor; Renal Cell Carcinoma; Pancreatic Cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MYLAN SM 25 MYLAN SM 25
Sunitinib Malate
- Imprint
- MYLAN SM 25 MYLAN SM 25
- Strength
- 25 mg
- Color
- Brown & Yellow
- Size
- 18.00 mm
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-6679
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
gelatin,
magnesium stearate,
mannitol,
sodium lauryl sulfate,
titanium dioxide,
ferric oxide red,
ferric oxide yellow,
ammonia,
ferrosoferric oxide,
propylene glycol,
shellac
Note: Inactive ingredients may vary.
Related images for "MYLAN SM 25 MYLAN SM 25"
More about sunitinib
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (35)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.